Natural Product: NPC489288

Natural Product IDNPC489288
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
LWTIZOHDKCIZPP-XHEWZUHNSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 21590534
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001552] Sesterterpenoids
          • [CHEMONTID:0002881] Cheilanthane sesterterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LWTIZOHDKCIZPP-XHEWZUHNSA-N
Standard InCHI InChI=1S/C25H38O4/c1-15-7-8-20-24(4,12-9-19-23(2,3)10-6-11-25(19,20)5)17(15)14-18(26)16-13-21(27)29-22(16)28/h13,17-20,22,26,28H,1,6-12,14H2,2-5H3/t17-,18?,19+,20+,22?,24+,25+/m1/s1
SMILES C=C1CC[C@H]2[C@@](C)(CC[C@H]3C(C)(C)CCC[C@]23C)[C@@H]1CC(C1=CC(=O)OC1O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   402.28 Volume:   433.982
?
Van der Waals volume.
Dense:   0.927 LogP:   3.632
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.635
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.798
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   23.0
TPSA:   66.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.528 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.816 Fsp3:   0.8
MCE-18:   76.044
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.534 Fluc inhibitor:   0.028
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.013
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.214 Promiscuous compounds:   0.04

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.638 MDCK Permeability:   -4.788
Pgp-inhibitor:   0.092 Pgp-substrate:   0.0
PAMPA:   0.334
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.006 30% Bioavailability (F30%):   0.077
50% Bioavailability (F50%):   0.682

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.031 MRP1:   0.064
Plasma Protein Binding (PPB):   97.819% Volume Distribution (VD):   0.106
Fu: 2.83%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.199
BSEP inhibitor:   0.882

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.003
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.005 CYP2C9-substrate:   0.06
CYP2D6-inhibitor:   0.998 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.999 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.035
HLM stability:   0.217
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  7.132 Half-life (T1/2):  1.158

ADMET: Toxicity

hERG Blockers:  0.051 hERG Blockers (10um):  0.403
Human Hepatotoxicity (H-HT):  0.658 Drug-induced Liver Injury (DILI):  0.761
AMES Toxicity:  0.607 Rat Oral Acute Toxicity:  0.559
Maximum Recommended Daily Dose:  0.893 Skin Sensitization:  0.97
Carcinogencity:  0.947 Eye Corrosion:  0.007
Eye Irritation:  0.765 Respiratory Toxicity:  0.817
Drug-induced Neurotoxicity:  0.35 Ototoxicity:  0.608
Hematotoxicity:  0.573 Drug-induced Nephrotoxicity:  0.93
Genotoxicity:  0.652 RPMI-8226 Immunitoxicity:  0.071
A549 Cytotoxicity:  0.188 Hek293 Cytotoxicity:  0.585
BCF:   2.219
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.137
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.958
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.488
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32608 ircinia sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[11277743]
NPO32608 ircinia sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[11908961]
NPO32608 ircinia sp. Species Irciniidae Eukaryota n.a. Okinawan n.a. PMID[12608859]
NPO32608 ircinia sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[18163586]
NPO32608 ircinia sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[7769397]
NPO32608 ircinia sp. Species Irciniidae Eukaryota n.a. Okinawan n.a. PMID[7853011]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1613 Individual protein Ribosomal protein S6 kinase alpha 5 Homo sapiens IC50 = 4000.0 nM PMID[11277743]
NPT1441 Individual protein MAP kinase-activated protein kinase 2 Homo sapiens IC50 = 90000.0 nM PMID[11277743]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC489288 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.94 High Similarity NPC472809
0.94 High Similarity NPC472810
0.6724 Remote Similarity NPC311070
0.6724 Remote Similarity NPC475709
0.6552 Remote Similarity NPC472812
0.6441 Remote Similarity NPC489285
0.6167 Remote Similarity NPC177037
0.6167 Remote Similarity NPC472814
0.5932 Remote Similarity NPC478392
0.5932 Remote Similarity NPC251528
0.5873 Remote Similarity NPC489287
0.5789 Remote Similarity NPC484730
0.5789 Remote Similarity NPC185587
0.5789 Remote Similarity NPC484729
0.569 Remote Similarity NPC35655
0.5588 Remote Similarity NPC324078
0.5574 Remote Similarity NPC217394
0.5484 Remote Similarity NPC79027
0.5246 Remote Similarity NPC99321
0.5238 Remote Similarity NPC472811
0.5167 Remote Similarity NPC484731
0.5167 Remote Similarity NPC189745
0.5167 Remote Similarity NPC175334
0.5161 Remote Similarity NPC12170
0.5082 Remote Similarity NPC478390
0.5079 Remote Similarity NPC470255

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC489288 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data